Rovatinex, capsules 50 pcs

Rovatinex is nephrolitholytic, antispasmodic, diuretic.

Pharmacodynamics

Rovatinex promotes the disintegration and excretion of renal stones and stones of the urinary tract.

The terpenes, such as borneol, undergo metabolic changes and are excreted in the urine – mainly in the form of glucuronides, which increases the solubility of calcium salts (major components of kidney and urinary tract stones). In a number of experiments on animals the inhibitory effect of Rovatinex on the formation of kidney stones and urinary tract stones has been established.

Rovatinex has an antispasmodic effect, promotes the passage of stones through the urinary tract, reduces pain of renal and ureteric colic, increases renal blood flow, improving their function and increasing diuresis.

It has anti-inflammatory, antimicrobial action (against a number of Gram-positive and Gram-negative microorganisms), increases the content of protective colloids and glucuronic acid in urine.

Pharmacokinetics

The terpenes present in Rovatinex are fat-soluble and rapidly absorbed.

The terpenes, such as borneol, undergo metabolic changes in the human body, becoming glucuronides, which are excreted in the urine.

Indications

Urinary stone disease (nephrolithiasis, urolithiasis); prevention of kidney and urinary tract stones formation.

Active ingredient

Composition

1 capsule contains:

The active ingredients:

pinene (α+β)31 mg; camphor 15 mg;

cineol 3 mg; phenchon4 mg;

Borneol 10 mg; anethol 4 mg;

Auxiliary substance:

olive oil;

Shell:

gelatin;

glycerol 85%;

sodium ethylparahydroxybenzoate;

p> sodium propyl parahydroxybenzoate;

quinoline yellow WS 70% (E104);

sunset yellow FCF 85% (E110).

How to take, the dosage

Ingestion, before meals.

Adults and children over 14 years of age: Unless otherwise directed by the physician, the usual dose is 1-2 capsules 3 times a day.

In case of renal colic, 2-3 capsules 4-5 times a day; children 6-14 years of age, 1 capsule 2 times a day.

Interaction

Caution should be exercised when using the drug in patients taking oral anticoagulants or other drugs that are metabolized in the liver.

Special Instructions

Rovatinex is not recommended for use in patients with severe renal colic, anuria or severe urinary tract infection.

In the course of treatment, fluid intake should be increased.

Contraindications

With caution: use of oral anticoagulants and drugs that are primarily metabolized in the liver.

Side effects

A small number of patients reported mild and transient gastric discomfort. Very rarely vomiting has been reported. In 2 cases, an intolerance to the drug was observed (cause unknown).

Overdose

Treatment: if the drug is taken recently, the stomach should be flushed, the patient should be monitored, using symptomatic treatment if necessary.

Cardiac, respiratory, renal and hepatic function monitoring is recommended.

Pregnancy use

It is not recommended for children under 6 years of age; in the first trimester of pregnancy and during lactation.